Global Influenza Vaccine Market Size study, by Vaccine Type (Quadrivalent, Trivalent), by Type (Seasonal, Pandemic), by Technology (Egg-based, Cell-based), by Age Group ( Pediatric, Adult), by Route Of Administration (Injection, Nasal Spray) and Regional Forecasts 2021-2027

BIZ4650454
200 Pages
September 2021
Pharmaceuticals

Download Sample Get Discount

Global Influenza Vaccine Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Influenza vaccinations contain three types of influenza viruses: influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. During the forecasted period, an increase in the occurrence of influenza epidemics and seasonal outbreaks is predicted to boost product sales. One of the key reasons driving market expansion is an increase in government support and monitoring of influenza vaccination on a national and worldwide level to monitor the availability, distribution, and administration of flu vaccines. Furthermore, rising government funding and increased investment by key market participants have permitted the launch of therapeutically effective vaccines, propelling the influenza vaccine market forward. The creation of a novel vaccine is a lengthy procedure that takes roughly 10-15 years to complete and test for safety and efficacy. Regulatory restrictions for clinical trials differ by country, potentially delaying the development of vaccines and limiting market expansion. Many firms are assisting with distribution, including Sanofi, Emergent BioSolutions Inc., and F. Hoffmann-La Roche Ltd. On the other side, due to rigorous requirements during clinical studies that extend vaccine delivery timetables, several nations are experiencing shortages and delays in vaccine approvals and availability. However, high cost associated in development of vaccines may impede market growth over the forecast period of 2021-2027.

The regional analysis of the Global Influenza Vaccine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to increased prevalence of influenza in the region. Whereas Middle East and Africa ( ROW) is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increase in awareness program, improvement in healthcare facilities, available disposable income, and rapid development of economic conditions across the region.

Major market player included in this report are:

AstraZeneca plc

Biodiem,

CSL Limited

Emergent BioSolutions

F. Hoffmann-La Roche Ltd.

Gamma Vaccines Pty Ltd.

GlaxoSmithKline plc

Merck & Co. Inc. (Merck Sharp & Dohme Corp.)

Novartis AG

Pfizer, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Vaccine Type:

Quadrivalent

Trivalent

By Type:

Seasonal

Pandemic

By Technology:

Egg-based

Cell-based

By Age Group:

Pediatric

Adult

By Route Of Administration:

Injection

Nasal Spray

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year –2018,2019

Base year –2020

Forecast period – 2021 to 2027.

Target Audience of the Global Influenza Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Influenza Vaccine Market , by Region, 2019-2027 (USD Billion)

1.2.2. Influenza Vaccine Market , by Vaccine Type, 2019-2027 (USD Billion)

1.2.3. Influenza Vaccine Market , by Type, 2019-2027 (USD Billion)

1.2.4. Influenza Vaccine Market , by Technology, 2019-2027 (USD Billion)

1.2.5. Influenza Vaccine Market , by Age Group, 2019-2027 (USD Billion)

1.2.6. Influenza Vaccine Market , by Route Of Administration, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Influenza Vaccine Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Influenza Vaccine Market Dynamics

3.1. Influenza Vaccine Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. High prevalence of influenza

3.1.1.2. Increase in government focus on immunization programs

3.1.2. Market Restraint

3.1.2.1. High costs associated with the development of vaccines

3.1.3. Market Opportunities

3.1.3.1. High growth prospects in emerging markets

Chapter 4. Global Influenza Vaccine Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Influenza Vaccine Market , by Vaccine Type

5.1. Market Snapshot

5.2. Global Influenza Vaccine Market by Vaccine Type , Performance - Potential Analysis

5.3. Global Influenza Vaccine Market Estimates & Forecasts by Vaccine Type 2018-2027 (USD Billion)

5.4. Influenza Vaccine Market , Sub Segment Analysis

5.4.1. Quadrivalent

5.4.2. Trivalent

Chapter 6. Global Influenza Vaccine Market , by Type

6.1. Market Snapshot

6.2. Global Influenza Vaccine Market by Type, Performance - Potential Analysis

6.3. Global Influenza Vaccine Market Estimates & Forecasts by Type 2018-2027 (USD Billion)

6.4. Influenza Vaccine Market , Sub Segment Analysis

6.4.1. Seasonal

6.4.2. Pandemic

Chapter 7. Global Influenza Vaccine Market , by Technology

7.1. Market Snapshot

7.2. Global Influenza Vaccine Market by Technology, Performance - Potential Analysis

7.3. Global Influenza Vaccine Market Estimates & Forecasts by Technology 2018-2027 (USD Billion)

7.4. Influenza Vaccine Market , Sub Segment Analysis

7.4.1. Egg-based

7.4.2. Cell-based

Chapter 8. Global Influenza Vaccine Market , by Age Group

8.1. Market Snapshot

8.2. Global Influenza Vaccine Market by Age Group, Performance - Potential Analysis

8.3. Global Influenza Vaccine Market Estimates & Forecasts by Age Group 2018-2027 (USD Billion)

8.4. Influenza Vaccine Market , Sub Segment Analysis

8.4.1. Pediatric

8.4.2. Adult

Chapter 9. Global Influenza Vaccine Market , by Route Of Administration

9.1. Market Snapshot

9.2. Global Influenza Vaccine Market by Route Of Administration, Performance - Potential Analysis

9.3. Global Influenza Vaccine Market Estimates & Forecasts by Route Of Administration 2018-2027 (USD Billion)

9.4. Influenza Vaccine Market , Sub Segment Analysis

9.4.1. Injection

9.4.2. Nasal Spray

Chapter 10. Global Influenza Vaccine Market , Regional Analysis

10.1. Influenza Vaccine Market , Regional Market Snapshot

10.2. North America Influenza Vaccine Market

10.2.1. U.S. Influenza Vaccine Market

10.2.1.1. Vaccine Type breakdown estimates & forecasts, 2018-2027

10.2.1.2. Type breakdown estimates & forecasts, 2018-2027

10.2.1.3. Technology breakdown estimates & forecasts, 2018-2027

10.2.1.4. Age Group breakdown estimates & forecasts, 2018-2027

10.2.1.5. Route Of Administration breakdown estimates & forecasts, 2018-2027

10.2.2. Canada Influenza Vaccine Market

10.3. Europe Influenza Vaccine Market Snapshot

10.3.1. U.K. Influenza Vaccine Market

10.3.2. Germany Influenza Vaccine Market

10.3.3. France Influenza Vaccine Market

10.3.4. Spain Influenza Vaccine Market

10.3.5. Italy Influenza Vaccine Market

10.3.6. Rest of Europe Influenza Vaccine Market

10.4. Asia-Pacific Influenza Vaccine Market Snapshot

10.4.1. China Influenza Vaccine Market

10.4.2. India Influenza Vaccine Market

10.4.3. Japan Influenza Vaccine Market

10.4.4. Australia Influenza Vaccine Market

10.4.5. South Korea Influenza Vaccine Market

10.4.6. Rest of Asia Pacific Influenza Vaccine Market

10.5. Latin America Influenza Vaccine Market Snapshot

10.5.1. Brazil Influenza Vaccine Market

10.5.2. Mexico Influenza Vaccine Market

10.6. Rest of The World Influenza Vaccine Market

Chapter 11. Competitive Intelligence

11.1. Top Market Strategies

11.2. Company Profiles

11.2.1. AstraZeneca plc.

11.2.1.1. Key Information

11.2.1.2. Overview

11.2.1.3. Financial (Subject to Data Availability)

11.2.1.4. Vaccine Type Summary

11.2.1.5. Recent Developments

11.2.2. Biodiem,

11.2.3. CSL Limited

11.2.4. Emergent BioSolutions

11.2.5. F. Hoffmann-La Roche Ltd.

11.2.6. Gamma Vaccines Pty Ltd.

11.2.7. GlaxoSmithKline plc

11.2.8. Merck & Co. Inc. (Merck Sharp & Dohme Corp.)

11.2.9. Novartis AG

11.2.10. Pfizer, Inc.

Chapter 12. Research Form

12.1. Research Form

12.1.1. Data Mining

12.1.2. Analysis

12.1.3. Market Estimation

12.1.4. Validation

12.1.5. Publishing

12.2. Research Attributes

12.3. Research Assumption

List of Tables

TABLE 1. Global Influenza Vaccine Market , report scope

TABLE 2. Global Influenza Vaccine Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Influenza Vaccine Market estimates & forecasts by Vaccine Type 2018-2027 (USD Billion)

TABLE 4. Global Influenza Vaccine Market estimates & forecasts by Type 2018-2027 (USD Billion)

TABLE 5. Global Influenza Vaccine Market estimates & forecasts by Technology 2018-2027 (USD Billion)

TABLE 6. Global Influenza Vaccine Market estimates & forecasts by Age Group 2018-2027 (USD Billion)

TABLE 7. Global Influenza Vaccine Market estimates & forecasts by Route Of Administration 2018-2027 (USD Billion)

TABLE 8. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. Global Influenza Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. Global Influenza Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. U.S. Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. U.S. Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. U.S. Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Canada Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. Canada Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. Canada Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. UK Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. UK Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. UK Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. Germany Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. Germany Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. Germany Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. France Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. France Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. France Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Spain Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Spain Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Spain Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Italy Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. Italy Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Italy Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. ROE Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. ROE Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. ROE Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. China Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. China Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. China Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. India Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. India Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. India Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Japan Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. Japan Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Japan Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. Australia Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 58. Australia Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. Australia Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 60. South Korea Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 61. South Korea Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. South Korea Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 63. ROPAC Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 64. ROPAC Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. ROPAC Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 66. Brazil Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 67. Brazil Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Brazil Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 69. Mexico Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 70. Mexico Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. Mexico Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 72. ROLA Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 73. ROLA Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROLA Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 75. ROW Influenza Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 76. ROW Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 77. ROW Influenza Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 78. List of secondary sources used in the study of global Influenza Vaccine Market .

TABLE 79. List of primary sources used in the study of global Influenza Vaccine Market .

TABLE 80. Years considered for the study.

TABLE 81. Exchange rates considered.

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Influenza Vaccine Market Size study, by Vaccine Type (Quadrivalent, Trivalent), by Type (Seasonal, Pandemic), by Technology (Egg-based, Cell-based), by Age Group ( Pediatric, Adult), by Route Of Administration (Injection, Nasal Spray) and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara